Global Biochips Market Research Report 2019 (Includes Business Impact of COVID-19)

                                          
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Biochips market.

Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Biochips market."
Biochips are bio-microsystems. Bio-microsystems are small integrated devices used for biochemical reactions, biological monitoring, research, academic studies, drug discovery, and much more. In simple terms, biochips are small sized chips that can perform multiple (generally thousands) biochemical reactions parallelly. A collection of microarrays or micro-test sites form these biochips. Microarrays when arranged on a surface made up of either glass or silicon, can perform large numbers of tests at the same. Thus, they help in cost and time saving.
North America accounted for the largest share of the biochips market in 2017. The large share of this regional segment can majorly be attributed to the rising geriatric population; increasing prevalence of lifestyle diseases, such as diabetes, asthma, and cardiac disorders; growing adoption of biochips; and a significant number of ongoing research activities and discoveries related to biochips in the North American region. In addition, major local companies have easy access to Biochips market, which makes it the largest and most significant market for suppliers. Asia-Pacific, on the other hand, is expected to grow at the highest CAGR over the next five years.

The global Biochips market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Biochips volume and value at global level, regional level and company level. From a global perspective, this report represents overall Biochips market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    Abbott
    Agilent Technologies
    Illumina
    PerkinElmer
    Thermo Fisher Scientific
    BioChain
    Bio-Rad Laboratories
    Cepheid
    EMD Millipore
    Fluidigm
    SuperBioChips Laboratories
    US Biomax
    Roche Diagnostics

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    DNA Chip
    Lab-on-a-Chip
    Protein Chip
    Others

Segment by Application
    Biotechnology and Pharmaceutical Companies
    Hospitals and Diagnostics Centers
    Academic & Research Institutes
    Other End Users